Atrial Fibrillation: News

• Alert Dabigatran Recalled Over Potential Carcinogen Ascend Labs issues voluntary nationwide recall of dabigatran etexilate capsules (75/150 mg) after detection of unacceptable levels of a nitrosamine impurity.
  News Alerts, March 23, 2023
• ACC/WCC 2023 Hormones for Gender Dysphoria Associated With Cardiovascular Risk Largest study to date examining risks of gender-affirming hormone therapy finds increased risks for some cardiovascular events, including notably stroke and heart attack.
  Medscape Medical News, March 10, 2023
• ACC/WCC 2023 AF Pulsed-Field Ablation Meets Pivotal Safety, Efficacy Goals The complication rate was "one of the lowest ever reported in a catheter ablation trial." In all, the emerging technology's performance was at least comparable to standard RF ablation.
  Medscape Medical News, March 07, 2023
• ACC/WCC 2023 Encouraging 3-Year Data for TAVR in Low-Risk Patients: EVOLUT The 3-year results show that low-surgical-risk patients undergoing aortic valve replacement continue to show lower rates of all-cause mortality and disabling stroke with TAVR compared with surgery.
  Medscape Medical News, March 06, 2023
• ACC/WCC 2023 NUDGE-FLU: Electronic 'Nudges' Boost Flu Shot Uptake in Seniors Two strategies based on electronically delivered letters or 'nudges' were found to increase flu shot uptake compared with usual care, a new study shows.
  Medscape Medical News, March 05, 2023
• ACC/WCC 2023 Transcatheter Tricuspid Valve Repair Effective, Safe for Regurgitation: TRILUMINATE TRILUMINATE, the first pivotal trial of a device for repair of severe tricuspid regurgitation, showed a large reduction in valve dysfunction associated with substantial improvement in quality of life.
  MDedge News, March 04, 2023
• ACC/WCC 2023 ACC Scientific Session Returns Live, Virtually to New Orleans The annual heart-health research showcase revisits the Crescent City with an accent on global health and insights for practice, including take-home pearls based on the latest guidelines.
  Medscape Medical News, February 27, 2023
• Silent Bradycardia Common on Loop Recorders, No Pacemaker Needed Long-term rhythm monitoring in a trial revealed six times as much bradycardia as was diagnosed in a usual-care clinical setting. What are the management implications?
  Medscape Medical News, February 22, 2023
• ISC 2023 STROKE AF at 3 Years: High AF Rate After Atherosclerotic Stroke These results suggest that continuous monitoring to detect AF should be considered in a larger population of stroke patients rather than just those with cryptogenic stroke, the investigators say.
  Medscape Medical News, February 09, 2023
• Acute Cardiac Events Common During COVID Hospitalization Acute cardiac events are common among adults hospitalized for COVID-19 and are associated with more severe outcomes, new results show.
  Medscape Medical News, February 06, 2023
• Cath Ablation for AF No Less Safe, Effective in Cancer Patients Freedom from recurrence or reablation and safety outcome were similar at 12 months regardless of whether patients had a recent cancer diagnosis or were on anthracyclines.
  First Look, February 03, 2023
• Accelerated Pacing a Possible Strategy for HF With Preserved EF? A study challenges the dogma of beta-blockers for HF with preserved ejection fraction. For now, the strategy might only be for HFpEF patients already with pacemakers.
  Medscape Medical News, February 02, 2023
• Alert FDA Approves Pirtobrutinib for R/R Mantle Cell Lymphoma This drug is the first BTK inhibitor approved to treat mantle cell lymphoma in this setting. Approval was based on overall response rates and duration of response in the phase 1/2 BRUIN trial.
  Medscape Medical News, January 27, 2023
• Cardio-Rheumatology Clinics Guide Care for Unique Population Cardio-rheumatology programs are "the newest child" in a series of cardiology offshoots. Such clinics aim to prevent and manage complex cardiovascular conditions in rheumatology patients.
  MDedge News, January 23, 2023
• Risk for New AF Climbs With Cardiometabolic Comorbidity Burden A larger burden of cardiometabolic disorders incurs a higher lifetime risk of atrial fibrillation, the effect more pronounced among women, suggests a cohort study.
  First Look, January 19, 2023
• Atrial Failure or Insufficiency: A New Syndrome The syndrome may explain heart failure in patients with preserved pump function, according to researchers.
  Medscape Medical News, January 13, 2023
• CAPLA Shows Limits of Further Ablation Post PVI in Persistent AF The trial argues against a common ablation add-on to standard pulmonary vein isolation in patients undergoing a first catheter ablation for persistent AF.
  Medscape Medical News, January 12, 2023
• Does EPA Lower CV Risk? REDUCE-IT Revisited After years of controversy, both skeptics and proponents of the REDUCE-IT study findings agree that a new trial may be desirable, but unlikely to happen.
  Medscape Medical News, January 11, 2023
• Some BP Meds Tied to Significantly Lower Risk for Dementia Antihypertensive medications that stimulate type 2 and 4 angiotensin II receptors may reduce the rate of dementia compared with those that inhibit these receptors, new research suggests.
  Medscape Medical News, January 10, 2023
• Warfarin Best for Thrombotic Antiphospholipid Syndrome? Patients with thrombotic antiphospholipid syndrome appear better treated with a vitamin K antagonist such as warfarin, rather than a direct oral anticoagulant, a new meta-analysis suggests.
  Medscape Medical News, January 10, 2023